Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial

BACKGROUND: A ready-to-use betamethasone valerate 0.1% (BMV) dressing was found to be superior to placebo dressing and a reference 0.1% BMV cream in the treatment of patients with chronic plaque psoriasis (CPP). METHODS: This multicentre, prospective, randomized, investigator-blinded, controlled, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortonne, J-P, Esposito, M, Chimenti, S, Kapińska-Mrowiecka, M, Grodzińska, A, Naldi, L, Frangione, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282443/
https://www.ncbi.nlm.nih.gov/pubmed/24256460
http://dx.doi.org/10.1111/jdv.12270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282443/
https://www.ncbi.nlm.nih.gov/pubmed/24256460
http://dx.doi.org/10.1111/jdv.12270

Ejemplares similares